Company intelligence
GeneDx
Empowering everyone to live their healthiest life through genomics
About GeneDx
We see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity™, the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx™ and GenomeDx™ tests – ranked #1 by expert geneticists and granted FDA Breakthrough Device Designation – enabling clinicians to deliver precise, fast, and actionable diagnoses. With over 25 years of innovation, more than 4,800 genetic diseases diagnosed, and over 1,000 scientific publications, we’re building the genomic intelligence network that’s shaping the future of precision medicine: for patients, providers, and partners alike.
Verified activity
Signals from GeneDx
23 published signals
Presence & Recognition
GeneDx launched a new educational series exploring real pediatric critical care cases where genomic answers helped guide more informed care decisions.
Reported by GeneDx
People
GeneDx employee Tori Al-Hark was named the August 1 Mindset Champion.
Reported by GeneDx
People
GeneDx employee Sarah Waltho was named the August 1 Best Pivot.
Reported by GeneDx
People
GeneDx employee Philippe Soares was named the August 1 Innovation Driver.
Reported by GeneDx
People
GeneDx employee Naho Harada was named the August 1 Customer Impact Star.
Reported by GeneDx
People
GeneDx employee Karlie Kaier was named the August 1 Cross-Functional Collaborator.
Reported by GeneDx
People
GeneDx is hiring a Customer Engagement Specialist to join the team onsite in Gaithersburg, MD, with a salary of $21-$26/hr.
Reported by Rodney Rael
Presence & Recognition
GeneDx is attending the CBGM 2026 conference to connect with experts and share how the company helps expand access to genomic insights.
Reported by GeneDx
Presence & Recognition
GeneDx shared key takeaways from an educational webinar with the National Association of Neonatal Nurses on the role of rapid genomic sequencing in neonatal care during NICU Awareness Month
Reported by GeneDx
Presence & Recognition
GeneDx is attending the Rare Trials Summit for a discussion on how genetically confirmed patient cohorts and real-world clinical data can help accelerate rare disease research and trial planning alongside leaders from UCB and Neurvati Neurosciences.
Reported by GeneDx
Customers & Market
GeneDx offers GeneDx tests for children with rare disease.
Reported by Lisa Gurry
Research & Knowledge
GeneDx and Canadian partners contributed to 15 peer-reviewed publications in the past ~18 months, including work that helped upgrade six genes and expand diagnostic knowledge for patients worldwide.
Reported by GeneDx
Research & Knowledge
GeneDx Decoded published new research from Seattle Children's exploring the impact of rapid genome sequencing beyond the ICU and its potential to support earlier answers across pediatric care settings.
Reported by GeneDx
Products & Services
GeneDx released Easy Order, a new way to simplify ExomeDx™ with CMA ordering for pediatric practices.
Reported by GeneDx
Products & Services
GeneDx integrated Epic Aura for streamlined exome-to-genome reflex testing.
Reported by GeneDx
Research & Knowledge
GeneDx published a study from Seattle Children's on expanding rapid genome sequencing beyond the ICU, finding that broader access to rapid genome sequencing was associated with a 35% diagnostic rate across pediatric inpatients, non-ICU inpatient wards had the highest diagnostic yield at 43%, and patients evaluated for faltering growth had the highest diagnostic yield at 63%.
Reported by Rian Hollister
Presence & Recognition
GeneDx employee Megan Nacar was honored as one of the 2026 Fierce 50 in the Leadership category by BLOC.
Reported by Megan Nacar
Products & Services
GeneDx transformed what carrier screening can tell prospective parents by offering preconception carrier screening during preconception visits.
Reported by Melissa Wolkon
Research & Knowledge
GeneDx highlights the importance of rapid genomic sequencing for critically ill infants suspected of genetic conditions, with results available in as soon as 48 hours.
Reported by GeneDx
Presence & Recognition
GeneDx CEO Katherine Stueland was named a 2026 Fierce Healthcare 50 honoree for Health Equity
Reported by GeneDx
Presence & Recognition
GeneDx announced that September 16th will be the event date for the partnership between GeneDx and Komodo Health to deliver insights on rare drug development.
Reported by Jessica Merritt
Research & Knowledge
GeneDx published new research showing that hundreds of different genetic variants associated with autism may converge on a smaller number of shared biological pathways.
Reported by Katherine Stueland
Research & Knowledge
GeneDx published a study in the journal Genetics in Medicine highlighting the benefits of rapid genome sequencing implemented across pediatric hospital care.
Reported by Lisa Gurry